Catalyst Wire Dossier Catalyst Wire Dossier

ALTU-135 CP

· Anthera Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALTU-135 CP, covering 2014-10-24 to 2014-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase III ALTU-135 CP Safety Trial [Phase 3]

See pricing